LAUREN SAUVE: Open Payments
NPI 1386186740 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 15 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $96 · 2025 $362
Food & beverage: $342Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| Gilead Sciences, Inc. | 4 | $89 |
| Geron Corporation | 2 | $71 |
| Aveo Pharmaceuticals, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $24 |
| Celgene Corporation | 1 | $19 |
| SERVIER PHARMACEUTICALS LLC | 1 | $16 |
| GENZYME CORPORATION | 1 | $15 |
Products named: KISQALI, Trodelvy, RYTELO, FOTIVDA, RYBREVANT, REBLOZYL, Tibsovo, AYVAKIT.
Industry payments across MI — which companies pay providers there.
